| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:184.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md, and National Heart, Lung, and Blood Institute, Cardiovascular Research Institute, Medstar Research Institute (J.Z., S.E.E.), Washington Hospital Center, Washington, DC.
Correspondence to Arshed A. Quyyumi, MD, Professor of Medicine (Cardiology), Emory University Hospital, Suite F606, 1364 Clifton Road NE, Atlanta, GA 30322.
Background Several microorganisms have been implicated in the pathogenesis of atherosclerosis. We hypothesized that infections may predispose to atherosclerosis by inflicting endothelial injury.
Methods and Results Of 375 patients undergoing coronary angiography, 218 had assessment of endothelial function using intracoronary acetylcholine (ACH) and of endothelium-independent function with sodium nitroprusside and adenosine. Immunoglobulin-G antibody titers to cytomegalovirus, Chlamydia pneumoniae, Helicobacter pylori, hepatitis A virus, and herpes simplex virus-1 were measured. Pathogen burden was defined as the number of positive antibodies. Although positive serology to individual pathogens tended to be associated with increased incidence of coronary arteriosclerosis (CAD), the pathogen burden correlated with the presence of CAD, even after adjustment for risk factors (OR 1.3; 95% CI, 1.05 to 1.6, P=0.018). Moreover, the severity of CAD was independently associated with the pathogen burden (P=0.001). Pathogen burden was an independent predictor of endothelial dysfunction, determined as the percent change in coronary vascular resistance in response to ACH (P=0.009) but not the responses to sodium nitroprusside or adenosine. Pathogen burden was also an independent determinant of endothelial function in the subgroup with angiographically normal coronary arteries.
Conclusions The immunoglobulin-G antibody response to multiple pathogens (pathogen burden) is an independent risk factor for endothelial dysfunction and the presence and severity of CAD. Endothelial dysfunction provides the crucial link by which pathogens may contribute to atherogenesis.
Key Words: atherosclerosis infection viruses endothelium coronary disease
This article has been cited by other articles:
![]() |
S. P. Didion Chlamydophila pneumoniae and Endothelial Activation: The Smoke That Precedes the Fire of Atherosclerosis? Circ. Res., April 25, 2008; 102(8): 861 - 863. [Full Text] [PDF] |
||||
![]() |
J. Goulding, R. Snelgrove, J. Saldana, A. Didierlaurent, M. Cavanagh, E. Gwyer, J. Wales, E. L. Wissinger, and T. Hussell Respiratory Infections: Do We Ever Recover? Proceedings of the ATS, December 1, 2007; 4(8): 618 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Steptoe, A Shamaei-Tousi, A Gylfe, B Henderson, S Bergstrom, and M Marmot Socioeconomic status, pathogen burden and cardiovascular disease risk Heart, December 1, 2007; 93(12): 1567 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Briet, C. Collin, S. Laurent, A. Tan, M. Azizi, M. Agharazii, X. Jeunemaitre, F. Alhenc-Gelas, and P. Boutouyrie Endothelial Function and Chronic Exposure to Air Pollution in Normal Male Subjects Hypertension, November 1, 2007; 50(5): 970 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-F. Dai, J.-W. Lin, J.-H. Kao, C.-N. Hsu, F.-T. Chiang, J.-L. Lin, Y.-H. Chou, K.-L. Hsu, C.-D. Tseng, Y.-Z. Tseng, et al. The Effects of Metabolic Syndrome Versus Infectious Burden on Inflammation, Severity of Coronary Atherosclerosis, and Major Adverse Cardiovascular Events J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2532 - 2537. [Abstract] [Full Text] [PDF] |
||||
![]() |
T W Weiss, H Kvakan, C Kaun, M Prager, W S Speidl, G Zorn, S Pfaffenberger, I Huk, G Maurer, K Huber, et al. No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis J. Clin. Pathol., November 1, 2006; 59(11): 1186 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Fernandez-Real, A. Lopez-Bermejo, J. Vendrell, M.-J. Ferri, M. Recasens, and W. Ricart Burden of Infection and Insulin Resistance in Healthy Middle-Aged Men Diabetes Care, May 1, 2006; 29(5): 1058 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Tousoulis, M Charakida, and C Stefanadis Endothelial function and inflammation in coronary artery disease Heart, April 1, 2006; 92(4): 441 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. M. Rogers, K. M. Langa, C. Kim, B. K. Nallamothu, L. F. McMahon Jr, P. N. Malani, B. E. Fries, S. R. Kaufman, and S. Saint Contribution of infection to increased mortality in women after cardiac surgery. Arch Intern Med, February 27, 2006; 166(4): 437 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shoenfeld, R. Gerli, A. Doria, E. Matsuura, M. M. Cerinic, N. Ronda, L. J. Jara, M. Abu-Shakra, P. L. Meroni, and Y. Sherer Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases Circulation, November 22, 2005; 112(21): 3337 - 3347. [Full Text] [PDF] |
||||
![]() |
J P J Halcox and J E Deanfield Childhood origins of endothelial dysfunction Heart, October 1, 2005; 91(10): 1272 - 1274. [Full Text] [PDF] |
||||
![]() |
Y. Neishi, S. Mochizuki, T. Miyasaka, T. Kawamoto, T. Kume, R. Sukmawan, M. Tsukiji, Y. Ogasawara, F. Kajiya, T. Akasaka, et al. Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration PNAS, August 9, 2005; 102(32): 11456 - 11461. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oshima, R. Ozono, Y. Yano, Y. Oishi, H. Teragawa, Y. Higashi, M. Yoshizumi, and M. Kambe Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1219 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Charakida, A. E. Donald, M. Terese, S. Leary, J. P. Halcox, A. Ness, G. D. Smith, J. Golding, P. Friberg, N. J. Klein, et al. Endothelial Dysfunction in Childhood Infection Circulation, April 5, 2005; 111(13): 1660 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ngeh and C. Goodbourn Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in Elderly Patients With Stroke (C-PEPS, M-PEPS, L-PEPS): A Case-Control Study on the Infectious Burden of Atypical Respiratory Pathogens in Elderly Patients With Acute Cerebrovascular Disease Stroke, February 1, 2005; 36(2): 259 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davi, M. Neri, A. Falco, D. Festi, T. Taraborelli, G. Ciabattoni, S. Basili, F. Cuccurullo, and C. Patrono Helicobacter Pylori Infection Causes Persistent Platelet Activation In Vivo Through Enhanced Lipid Peroxidation Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 246 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vita, J. F. Keaney Jr, M. G. Larson, M. J. Keyes, J. M. Massaro, I. Lipinska, B. T. Lehman, S. Fan, E. Osypiuk, P. W.F. Wilson, et al. Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study Circulation, December 7, 2004; 110(23): 3604 - 3609. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Miller, G. Rodgers, J. A. Charlesworth, B. Kirkland, S. R. Severson, T. E. Rasmussen, M. Yagubyan, J. C. Rodgers, F. R. Cockerill III, R. L. Folk, et al. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1115 - H1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vita, M.-L. Brennan, N. Gokce, S. A. Mann, M. Goormastic, M. H. Shishehbor, M. S. Penn, J. F. Keaney Jr, and S. L. Hazen Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans Circulation, August 31, 2004; 110(9): 1134 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Wessel, C. B. Arant, and C. J. Pepine Commentary on "New and Emerging Theories of Cardiovascular Disease" Biol Res Nurs, July 1, 2004; 6(1): 17 - 20. [PDF] |
||||
![]() |
R. Paoletti, A. M. Gotto Jr, and D. P. Hajjar Inflammation in Atherosclerosis and Implications for Therapy Circulation, June 15, 2004; 109(23_suppl_1): III-20 - III-26. [Abstract] [Full Text] |
||||
![]() |
U. Landmesser, B. Hornig, and H. Drexler Endothelial Function: A Critical Determinant in Atherosclerosis? Circulation, June 1, 2004; 109(21_suppl_1): II-27 - II-33. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zal, J. C. Kaski, G. Arno, J. P. Akiyu, Q. Xu, D. Cole, M. Whelan, N. Russell, J. A. Madrigal, I. A. Dodi, et al. Heat-Shock Protein 60-Reactive CD4+CD28null T Cells in Patients With Acute Coronary Syndromes Circulation, March 16, 2004; 109(10): 1230 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Kaski, P. Khairy, S. Rinfret, J.-C. Tardif, R. Marchand, S. Shapiro, J. Brophy, and J. Dupuis Infection, Endothelial Dysfunction, and Atherogenesis * Response Circulation, December 23, 2003; 108(25): e171 - 172. [Full Text] [PDF] |
||||
![]() |
M. E. Widlansky, N. Gokce, J. F. Keaney Jr, and J. A. Vita The clinical implications of endothelial dysfunction J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1149 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. N. Khot, M. B. Khot, C. T. Bajzer, S. K. Sapp, E. M. Ohman, S. J. Brener, S. G. Ellis, A. M. Lincoff, and E. J. Topol Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease JAMA, August 20, 2003; 290(7): 898 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grahame-Clarke, N. N. Chan, D. Andrew, G. L. Ridgway, D. J. Betteridge, V. Emery, H. M. Colhoun, and P. Vallance Human Cytomegalovirus Seropositivity Is Associated With Impaired Vascular Function Circulation, August 12, 2003; 108(6): 678 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Boekholdt, W. R.P. Agema, R. J.G. Peters, A. H. Zwinderman, E. E. van der Wall, P. H. Reitsma, J. J.P. Kastelein, and J. W. Jukema Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular Events Circulation, May 20, 2003; 107(19): 2416 - 2421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rupp and M. Maass Egr-1, a Major Link Between Infection and Atherosclerosis? Circ. Res., May 16, 2003; 92(9): e78 - 78. [Full Text] [PDF] |
||||
![]() |
P. Khairy, S. Rinfret, J.-C. Tardif, R. Marchand, S. Shapiro, J. Brophy, and J. Dupuis Absence of Association Between Infectious Agents and Endothelial Function in Healthy Young Men Circulation, April 22, 2003; 107(15): 1966 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.M. Fischbacher, R. Bhopal, C.C. Blackwell, R. Ingram, N.C. Unwin, M. White, and K.G.M.M. Alberti IgG Is Higher in South Asians Than Europeans: Does Infection Contribute to Ethnic Variation In Cardiovascular Disease? Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 703 - 704. [Full Text] [PDF] |
||||
![]() |
J. B. Muhlestein and J. L. Anderson Infectious Serology and Atherosclerosis: How Burdensome Is the Risk? Circulation, January 21, 2003; 107(2): 220 - 222. [Full Text] [PDF] |
||||
![]() |
J. A. Vita and J. Loscalzo Shouldering the Risk Factor Burden: Infection, Atherosclerosis, and the Vascular Endothelium Circulation, July 9, 2002; 106(2): 164 - 166. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |